Study on B7-H3 Targeted Affibody Radioligand Probes for PET Imaging of Solid Tumors

NCT06454955 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

B7H3
CD276 Affibody
PET/CT Imaing

Interventions

DRUG: [68Ga] B7H3 Affibody-BCH

Sponsor

Peking University Cancer Hospital & Institute